Pseudornonas exotoxin (PE) is a bacterial protein produced by €3. aeruginosa that is toxic for most mammalian cells [for reviews see 1, 21. The mature protein is a proenzyme and, after activation, exhibits both NAD hydrolase activity and ADP-ribosyltransferase activity. When added to mammalian cells the toxin binds to the alpha 2-macroglobulin receptor which mediates internalization to the endosoma1 compartment [ 31. In the endosome the toxin is cleaved ('nicked') by a cellular protease. Disulphide bond reduction then results in the release of an enzymatically active toxin fragment which translocates to the cytosol where it inhibits protein synthesis. In the cytosol; PE hydrolyses NAD and transfers the ADP-ribose moiety of NAD to elongation factor 2 (EF-2). When EF-2 is modified in this way it can no longer participate in the synthesis of new protein. The inactivation of EF-2 is lethal for the cell.
Pseudomonas exotoxin: structure and function
Pseudornonas exotoxin (PE) is a bacterial protein produced by €3. aeruginosa that is toxic for most mammalian cells [for reviews see 1, 21. The mature protein is a proenzyme and, after activation, exhibits both NAD hydrolase activity and ADP-ribosyltransferase activity. When added to mammalian cells the toxin binds to the alpha 2-macroglobulin receptor which mediates internalization to the endosoma1 compartment [ 31. In the endosome the toxin is cleaved ('nicked') by a cellular protease. Disulphide bond reduction then results in the release of an enzymatically active toxin fragment which translocates to the cytosol where it inhibits protein synthesis. In the cytosol; PE hydrolyses NAD and transfers the ADP-ribose moiety of NAD to elongation factor 2 (EF-2). When EF-2 is modified in this way it can no longer participate in the synthesis of new protein. The inactivation of EF-2 is lethal for the cell.
Structural analysis of PE crystals by McKay and colleagues [4] revealed three prominent domains. These were termed domains I, 11, and 111: domain I was further divided into domains Ia and Ib. This study was followed first by a deletion analysis of the structural gene [5] and then by many individual studies focused on determining the location of important sequences within each domain. The results from all these studies has revealed that domain Ia (amino acids 1-252) is responsible for the toxin binding to its surface receptor; domain I1 (amino acids 253-364) is the substrate for the cellular protease and, after cleavage, has translocating activity; domain Ib (amino acids 365-399) has no known function and most of it can be deleted without loss of toxin activity; and domain I11 (amino acids 400-61 3) has the ADP-ribosylating activity and contains an endoplasmic retention sequence.
A closer look at the interactions of PE with cells has revealed that a lysine at position 57 in domain I is needed for cell binding [6] . Changing this basic residue to an acidic residue such as glutamic acid or inserting a dipeptide reduces binding by 100-fold. After binding the toxin is Abbreviations used: PI.:, Pseudomonas exotoxin; EF-2, elongation factor-2; Ab, antibody.
internalized and cleaved within the endosomal compartment. Cleavage occurs in an arginine-rich loop. Specifically, the peptide bond between arginine 279 and glycine 280 is broken. The toxin is then held together by the disulphide bond that joins cystine 265 with cystine 287. While it is clear that the reduction of this bond is needed to produce an enzymatically active C-terminal fragment of 37 kDa, neither the intracellular location of the reduction step nor the mechanism of reduction are known. After reduction the 37 kDa fragment translocates to the cytosol 171. Translocation is only successful if PE has an endoplasmic retention-like sequence at its C-terminus 181. The sequence at the C-terminus of native PE is REDLK. When this is changed to KDEI, a mutant toxin is generated with slightly enhanced (3-fold) toxicity. However, if this sequence is jumbled, extended with other amino acids or removed, there is no toxicity for cells, indicating that an interaction with the endoplasmic reticulum is an important step for toxin translocation to the cytosol. In the cytosol, the C-terminal fragment ADP-ribosylates EF-2. To do this it binds NAD, hydrolyses it, and then transfers the ADPribose portion. Glutamic acid 553 has been shown to be important for NAD binding [9] (see Fig. 1 for summary of PE pathway).
Targeting PE to diseased cells
Because of its potency, PE has been joined to various targeting ligands and directed to kill specific populations of cells [2, 101. In early experiments native PE was conjugated chemically to epidermal growth factor 1111 or various monoclonal antibodies [12, 131. These conjugates were active against receptor-positive or antigen-positive cells but retained some of the toxicities of native PE since no major structural changes had been imposed on the toxin. It was not until recombinant versions of the toxin that lacked the toxin's binding domain, termed PE40, were available, that it was possible to make conjugates with high specificity for target cells and low toxicity for normal tissue [2, 141. Because PE40 lacked binding activity but retained the portions of PE responsible for translocation and enzyme activity, it was considered a suitable candidate for making toxin conjugates. Experiments in this regard involved attaching PE40 
Construction of recombinant conjugates with PE and its derivatives
The removal of domain Ia eliminates toxin binding but also produces a molecule which can be redirected simply by adding binding ligands of known specificity. As mentioned this can be done in one of two different ways. The PE40 protein can be produced in large amounts in Escherichziz coli and then purified. It is then conjugated to various monoclonal antibodies. When PE40 was conjugated to the following antibodies, active immunotoxins were produced: antitransferrin receptor (HB21) [ 14, 211, [ 141 anti-adenocarcinoma antibody (B3) [16] . These immunotoxins were prepared by using heterobifunctional cross linking agents that formed thioether linkages. When these immunotoxins were targeted to a variety of carcinomas or leukaemic cell lines, they had potent cytotoxic activity.
The removal of the DNA encoding domain Ia and the replacement of it with a specific cDNA also allowed for the construction of gene fusions. The cDNA insert then targets the toxicity of the fusion protein. This strategy has been used to construct a variety of growth factor-toxin, cytokine-toxin and antibody-toxin fusions proteins.
The cDNA for the growth factor, cytokine or antibody is placed at the 5' end of the fusion. This is in contrast to the situation with the gene fusions involving diphtheria toxin where the growth factor is positioned at the 3' end [22] . 
Antibody-PE conjugates and chimerics
Currently antibody-PE (Ab-PE) immunotoxins are made in two different ways. PE40 is chemically attached to a native antibody molecule, or a recombinant Ab-PE40 chimeric is constructed by combining the cDNA for an Ab single chain Fv fragment with the DNA for PE40. Each type of immunotoxin has distinct properties (see Fig. 2 ). By analysing the results of experimentation with these immunotoxins, insights into toxin-related issues concerning cell biology, animal physiology, pathology and pharmacology can be gained.
In early experiments, conjugating native PE to 
Properties of PE40 immunotoxins
When PE40 is attached chemically t o a monoclonal antibody the following general properties can be expected: the size of the I : I conjugate will be 19OooO Da; the half-life after IV injection will be approximately 2-5 h; the antibody will be bivalent, and unless attachment of PE40 is close t o the combining site, there will be no loss of binding affinity; and conjugates can be made with relatively high efficiency: 20% of starting material is typical. When the P E N gene is fused with a single chain (Fv) antibody the following properties can be expected: the size will be 65000 Da; the half-life after injection will be approximately 15-20 rnin; unlike the chemical conjugates, there will be a precise attachment of antibody sequences with the toxin; there is usually a 3-5-fold decline in binding affinity due t o the rnonovalent nature of the construction: and recovery of correctly folded material is only 5-10%.
Ab /s-s\ 3 11. Recombinant immunotoxins are expressed in E. coli and purified from inclusion bodies. In contrast to chemical conjugates, where the toxin molecule is attached to the antibody molecule at residues with a primary amino group, recombinant immunotoxins are homogeneous in their primary structure. Other ways in which the chemically and genetically constructed immunotoxins differ, include the size of the final product, the lack of an Fc segment in Fv-PE40 and the fact that the recombinant immunotoxin has only one antigen binding site (see Fig. 1 ). In tissue culture experiments single chain antibody Fv-PE40 immunotoxins often exhibit higher potency for target cells than do the corresponding conjugates made with whole antibody chemically linked to PE40. This result is seen despite the fact that Fv-PE40 immunotoxins have only one antigen-binding site and usually have a three-five-fold lower binding affinity for antigen compared with native antibody [20] . It is posible that the positioning of PE40 relative to the Fv is optimal for toxin processing within target cells and that this compensates for the lower binding affinity.
Further experimentation and clinical evaluation is clearly needed before a full understanding can be gained both of the mechanisms of action of PE immunotoxins and their usefulness for the treatment of disease.
Introduction
Ricin is a heterodimeric plant protein which is potently cytotoxic to mammalian cells. Both polypeptide subunits of ricin have distinct roles in the intoxication process [ 11. The A subunit (RTA) is a ribosomal RNA N-glycosidase which, having entered the target cell cytosol, specifically removes an adenine residue from 28s rRNA (A4324 in the case of rat liver 28s rRNA) [2, 31. This particular adenine residue, which is present in a highly conserved, surface-exposed loop in 28s rRNA, has a crucial role in the binding of elongation factors during translation. Ribosomes containing depurinated 28s RNA are no longer capable of protein synthesis. The ricin B subunit (RTB) is a lectin which has two galactose binding sites. Interaction between these sites and galactosides present on plasma membrane glycoproteins or glycolipids bind the holotoxin to the surface of target cells [ 11.
After endocytic uptake of surface-bound toxin, the B subunit is believed to have a further function in Abbreviations used: RTA, rich A subunit; RTB, ricin B subunit; TGN, trans Golgi network; BFA, brefeldin A, EK, endoplasmic reticulum. that it facilitates, either directly or indirectly, delivery of the toxic A subunit into the target cell cytosol.
Role of RTB in cytotoxicity
The notion that RTB has two functional roles in the intoxication process, binding to cell surface galactose residues and facilitating RTA translocation into the cell cytosol (hereinafter referred to as the binding and translocation functions) arose from studies with ricin-containing immunotoxins. Initially RTA and RTB were separated by reducing the intrachain disulphide bond, and RTA was purified to homogeneity. The RTA was then conjugated via a disulphide bond to a monoclonal antibody raised against a cell type-specific surface antigen. In spite of binding readily to cells bearing the relevant antigen, such RTA-containing immunotoxins frequently displayed disappointingly low cytotoxicity [4] . In contrast, corresponding immunotoxins in which whole ricin was conjugated to the antibody were potently cytotoxic, even when surface binding
